Pfizer/BioNTech COVID-19 booster 95.6% effective against disease: study
A 30-microgram booster dose showed a relative vaccine efficacy of 95.6% in individuals who had previously received the Pfizer/BioNTech primary two-dose series, the companies announced.
via DigioNews Markets
Note : I Hope My My New News Article : Pfizer/BioNTech COVID-19 booster 95.6% effective against disease: study Of DigioNews So You Trust My site you are always updated with Latest news Daily news Everyday. Only on DigioNews : Pfizer/BioNTech COVID-19 booster 95.6% effective against disease: study
0 Comments